Literature DB >> 8891642

The ability to produce express saccades as a function of gap interval among schizophrenia patients.

B A Clementz1.   

Abstract

The ability to produce "express saccades" is associated with adequate functioning of saccadic burst cells in the superior colliculus. Saccadic burst cells appear to be under the inhibitory control of both the collicular and the dorsolateral frontal fixation systems. Twenty schizophrenia patients and 20 nonpsychiatric subjects were presented a saccade task that included five different gap intervals (0, 100, 200, 300, and 400 ms) between fixation point offset and peripheral target onset (at +/-4 degrees). All subjects generated the highest frequency of express saccades in trials with a gap interval of 200 ms. Schizophrenia patients had an increased frequency of express saccades across gap intervals, especially for targets presented in the right visual field. The groups did not differ in the percentages of anticipatory saccades or saccadic amplitudes. These results suggest that schizophrenia patients' saccadic burst cells in the superior colliculus are functioning adequately, but may be consistent with dysfunction of dorsolateral frontal cortex and/or its interconnecting subcortical circuitry.

Entities:  

Mesh:

Year:  1996        PMID: 8891642     DOI: 10.1007/bf00229561

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  42 in total

1.  Express saccades: is there a separate population in humans?

Authors:  M G Wenban-Smith; J M Findlay
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Skewness in commingled distributions.

Authors:  C J Maclean; N E Morton; R C Elston; S Yee
Journal:  Biometrics       Date:  1976-09       Impact factor: 2.571

3.  Fixation cells in monkey superior colliculus. I. Characteristics of cell discharge.

Authors:  D P Munoz; R H Wurtz
Journal:  J Neurophysiol       Date:  1993-08       Impact factor: 2.714

4.  Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems.

Authors:  O Rascol; M Clanet; J L Montastruc; M Simonetta; M J Soulier-Esteve; B Doyon; A Rascol
Journal:  Brain       Date:  1989-10       Impact factor: 13.501

Review 5.  Frontal-subcortical circuits and human behavior.

Authors:  J L Cummings
Journal:  Arch Neurol       Date:  1993-08

6.  Separate populations of visually guided saccades in humans: reaction times and amplitudes.

Authors:  B Fischer; H Weber; M Biscaldi; F Aiple; P Otto; V Stuhr
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  Saccadic system functioning among schizophrenia patients and their first-degree biological relatives.

Authors:  B A Clementz; J E McDowell; S Zisook
Journal:  J Abnorm Psychol       Date:  1994-05

8.  Timing and amplitude of saccades during predictive saccadic tracking in schizophrenia.

Authors:  J E McDowell; B A Clementz; J T Wixted
Journal:  Psychophysiology       Date:  1996-01       Impact factor: 4.016

9.  The effect of frontal eye field and superior colliculus lesions on saccadic latencies in the rhesus monkey.

Authors:  P H Schiller; J H Sandell; J H Maunsell
Journal:  J Neurophysiol       Date:  1987-04       Impact factor: 2.714

10.  Reversal of asymmetry of the planum temporale in schizophrenia.

Authors:  R G Petty; P E Barta; G D Pearlson; I K McGilchrist; R W Lewis; A Y Tien; A Pulver; D D Vaughn; M F Casanova; R E Powers
Journal:  Am J Psychiatry       Date:  1995-05       Impact factor: 18.112

View more
  10 in total

1.  Preparatory activations across a distributed cortical network determine production of express saccades in humans.

Authors:  Jordan P Hamm; Kara A Dyckman; Lauren E Ethridge; Jennifer E McDowell; Brett A Clementz
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  Pre-cue fronto-occipital alpha phase and distributed cortical oscillations predict failures of cognitive control.

Authors:  Jordan P Hamm; Kara A Dyckman; Jennifer E McDowell; Brett A Clementz
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

3.  Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.

Authors:  Brett A Clementz; John A Sweeney; Jordan P Hamm; Elena I Ivleva; Lauren E Ethridge; Godfrey D Pearlson; Matcheri S Keshavan; Carol A Tamminga
Journal:  Am J Psychiatry       Date:  2015-12-07       Impact factor: 18.112

4.  Saccadic performance characteristics and the behavioural neurology of Tourette's syndrome.

Authors:  R H Farber; N R Swerdlow; B A Clementz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

Review 5.  Alpha oscillations and the control of voluntary saccadic behavior.

Authors:  Jordan P Hamm; Dean Sabatinelli; Brett A Clementz
Journal:  Exp Brain Res       Date:  2012-07-11       Impact factor: 1.972

Review 6.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

Review 7.  Neurophysiology and neuroanatomy of reflexive and volitional saccades: evidence from studies of humans.

Authors:  Jennifer E McDowell; Kara A Dyckman; Benjamin P Austin; Brett A Clementz
Journal:  Brain Cogn       Date:  2008-10-05       Impact factor: 2.310

8.  Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia.

Authors:  James L Reilly; Margret S H Harris; Tin T Khine; Matcheri S Keshavan; John A Sweeney
Journal:  Biol Psychiatry       Date:  2008-01-11       Impact factor: 13.382

9.  Compromised speed discrimination among schizophrenia patients when viewing smooth pursuit targets.

Authors:  Brett A Clementz; Jennifer E McDowell; Karen R Dobkins
Journal:  Schizophr Res       Date:  2007-07-12       Impact factor: 4.939

10.  Express saccades in distinct populations: east, west, and in-between.

Authors:  Paul C Knox; Felicity D A Wolohan; Mai S Helmy
Journal:  Exp Brain Res       Date:  2017-09-27       Impact factor: 1.972

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.